Skeletal Muscle Loss During Neoadjuvant Chemotherapy for Breast Cancer: Diabetes as an Independent Predictor

Objective: This study examined body composition changes during neoadjuvant chemotherapy (NACT) for breast cancer and aimed to identify clinical parameters associated with skeletal muscle loss. Materials and Methods: We retrospectively analyzed women with stage I–III breast cancer who received NACT....

Descripció completa

Dades bibliogràfiques

Autors principals:	Zeki Gökhan Sürmeli, Ahmet Aslan, Mohamed Gado, Saifuddin Aljowder, Muhammad Sajid, Samrin Liaqat, Nawaf Alkhalfan, Hiba Abduljawad, Taha Avcı, Mustafa Kula
Format:	Artigo
Idioma:	Inglês
Publicat:	Galenos Publishing House 2026-04-01
Col·lecció:	European Journal of Breast Health
Matèries:	body composition breast cancer diabetes neoadjuvant chemotherapy sarcopenia
Accés en línia:	https://www.eurjbreasthealth.com/articles/skeletal-muscle-loss-during-neoadjuvant-chemotherapy-for-breast-cancer-diabetes-as-an-independent-predictor/doi/ejbh.galenos.2025.2025-9-9
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!